공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 OTC 의약품 시장

Over the Counter (OTC) Drugs

리서치사 Global Industry Analysts, Inc.
발행일 2021년 04월 상품 코드 997525
페이지 정보 영문 201 Pages
가격
US $ 4,950 ₩ 5,625,000 PDF (Single User License) help
DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste 가 되지 않으며, 인쇄는 1회에 한해 가능합니다. 인쇄물 이용은 PDF 라이선스 소유자로 한정됩니다.
US $ 14,850 ₩ 16,875,000 PDF (Global License to Company and its Fully-owned Subsidiaries) help
동일 기업 및 100% 자회사의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 OTC 의약품 시장 Over the Counter (OTC) Drugs
발행일 : 2021년 04월 페이지 정보 : 영문 201 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 OTC 의약품 시장 규모는 분석기간(2020-2027년)에 5.3%의 연평균 복합 성장률(CAGR)로 성장할 전망이며, 2020년 1,463억 달러에서 2027년에는 2,103억 달러에 달할 것으로 예측됩니다.

본 보고서에서 분석한 부문 중 하나인 기침/감기는 분석기간 중 5.1%의 CAGR을 나타내고, 545억 달러에 달할 전망입니다.

세계의 OTC 의약품(OTC Drug) 시장에 대해 조사했으며, 시장 점유율, COVID-19의 영향, 동향 및 성장요인, 지역별 시장 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

조사 대상 기업 예

  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Novartis AG
  • Pfizer, Inc.
  • Sanofi SA
  • Takeda Pharmaceutical Co., Ltd.

목차

I. 조사 방법

II. 개요

  • 시장 개요
    • 인플루언서 시장 인사이트
    • 세계 시장 궤적
    • 코로나19(COVID-19)의 영향과 다가오는 세계 경기침체
  • 주요 기업
  • 동향 및 성장요인
  • 세계 시장 전망

III. 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

IV. 경쟁

  • 기업 개요 : 42개사
LSH 21.04.08

Abstract:

Global Over the Counter (OTC) Drugs Market to Reach $210.3 Billion by 2027

Amid the COVID-19 crisis, the global market for Over the Counter (OTC) Drugs estimated at US$146.3 Billion in the year 2020, is projected to reach a revised size of US$210.3 Billion by 2027, growing at a CAGR of 5.3% over the analysis period 2020-2027. Cough, Cold & Flu, one of the segments analyzed in the report, is projected to record a 5.1% CAGR and reach US$54.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Analgesics segment is readjusted to a revised 4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $39.6 Billion, While China is Forecast to Grow at 8.1% CAGR

The Over the Counter (OTC) Drugs market in the U.S. is estimated at US$39.6 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$43.4 Billion by the year 2027 trailing a CAGR of 8.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.9% and 4.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Dermatology Products Segment to Record 5.5% CAGR

In the global Dermatology Products segment, USA, Canada, Japan, China and Europe will drive the 5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$11 Billion in the year 2020 will reach a projected size of US$15.5 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$28.2 Billion by the year 2027, while Latin America will expand at a 6.7% CAGR through the analysis period.

Select Competitors (Total 42 Featured) -

  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Novartis AG
  • Pfizer, Inc.
  • Sanofi SA
  • Takeda Pharmaceutical Co., Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Over the Counter (OTC) Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Over the Counter (OTC) Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Over the Counter (OTC) Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Cough, Cold & Flu by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Cough, Cold & Flu by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Cough, Cold & Flu by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Analgesics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Analgesics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Analgesics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Dermatology Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Dermatology Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Dermatology Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Gastrointestinal Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Gastrointestinal Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Gastrointestinal Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Minerals & Vitamins Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Minerals & Vitamins Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Minerals & Vitamins Supplements by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Weight Loss/Dietary Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Weight Loss/Dietary Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Weight Loss/Dietary Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Ophthalmic Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Ophthalmic Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Ophthalmic Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for Sleep Aids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 26: World Historic Review for Sleep Aids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 27: World 15-Year Perspective for Sleep Aids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 28: World Current & Future Analysis for Other Categories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 29: World Historic Review for Other Categories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 30: World 15-Year Perspective for Other Categories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 31: USA Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 32: USA Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 33: USA 15-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 34: Canada Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 35: Canada Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 36: Canada 15-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 37: Japan Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Japan Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 39: Japan 15-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 40: China Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 41: China Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 42: China 15-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 43: Europe Current & Future Analysis for Over the Counter (OTC) Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 44: Europe Historic Review for Over the Counter (OTC) Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 45: Europe 15-Year Perspective for Over the Counter (OTC) Drugs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 46: Europe Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 47: Europe Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 48: Europe 15-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 49: France Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 50: France Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 51: France 15-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 52: Germany Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Germany Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 54: Germany 15-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 55: Italy Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Italy Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 57: Italy 15-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 58: UK Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 59: UK Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 60: UK 15-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories for the Years 2012, 2020 & 2027
  • SPAIN
    • TABLE 61: Spain Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 62: Spain Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 63: Spain 15-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories for the Years 2012, 2020 & 2027
  • RUSSIA
    • TABLE 64: Russia Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 65: Russia Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 66: Russia 15-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 67: Rest of Europe Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Rest of Europe Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 69: Rest of Europe 15-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 70: Asia-Pacific Current & Future Analysis for Over the Counter (OTC) Drugs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 71: Asia-Pacific Historic Review for Over the Counter (OTC) Drugs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 72: Asia-Pacific 15-Year Perspective for Over the Counter (OTC) Drugs by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
    • TABLE 73: Asia-Pacific Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Asia-Pacific Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 75: Asia-Pacific 15-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories for the Years 2012, 2020 & 2027
  • AUSTRALIA
    • TABLE 76: Australia Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 77: Australia Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 78: Australia 15-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories for the Years 2012, 2020 & 2027
  • INDIA
    • TABLE 79: India Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 80: India Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 81: India 15-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories for the Years 2012, 2020 & 2027
  • SOUTH KOREA
    • TABLE 82: South Korea Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 83: South Korea Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 84: South Korea 15-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories for the Years 2012, 2020 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 85: Rest of Asia-Pacific Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Rest of Asia-Pacific Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 87: Rest of Asia-Pacific 15-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories for the Years 2012, 2020 & 2027
  • LATIN AMERICA
    • TABLE 88: Latin America Current & Future Analysis for Over the Counter (OTC) Drugs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 89: Latin America Historic Review for Over the Counter (OTC) Drugs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 90: Latin America 15-Year Perspective for Over the Counter (OTC) Drugs by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
    • TABLE 91: Latin America Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Latin America Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 93: Latin America 15-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories for the Years 2012, 2020 & 2027
  • ARGENTINA
    • TABLE 94: Argentina Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Argentina Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 96: Argentina 15-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories for the Years 2012, 2020 & 2027
  • BRAZIL
    • TABLE 97: Brazil Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Brazil Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 99: Brazil 15-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories for the Years 2012, 2020 & 2027
  • MEXICO
    • TABLE 100: Mexico Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 101: Mexico Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 102: Mexico 15-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories for the Years 2012, 2020 & 2027
  • REST OF LATIN AMERICA
    • TABLE 103: Rest of Latin America Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 104: Rest of Latin America Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 105: Rest of Latin America 15-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories for the Years 2012, 2020 & 2027
  • MIDDLE EAST
    • TABLE 106: Middle East Current & Future Analysis for Over the Counter (OTC) Drugs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 107: Middle East Historic Review for Over the Counter (OTC) Drugs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 108: Middle East 15-Year Perspective for Over the Counter (OTC) Drugs by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
    • TABLE 109: Middle East Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 110: Middle East Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 111: Middle East 15-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories for the Years 2012, 2020 & 2027
  • IRAN
    • TABLE 112: Iran Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 113: Iran Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 114: Iran 15-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories for the Years 2012, 2020 & 2027
  • ISRAEL
    • TABLE 115: Israel Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 116: Israel Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 117: Israel 15-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories for the Years 2012, 2020 & 2027
  • SAUDI ARABIA
    • TABLE 118: Saudi Arabia Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 119: Saudi Arabia Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 120: Saudi Arabia 15-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories for the Years 2012, 2020 & 2027
  • UNITED ARAB EMIRATES
    • TABLE 121: UAE Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 122: UAE Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 123: UAE 15-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories for the Years 2012, 2020 & 2027
  • REST OF MIDDLE EAST
    • TABLE 124: Rest of Middle East Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 125: Rest of Middle East Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 126: Rest of Middle East 15-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories for the Years 2012, 2020 & 2027
  • AFRICA
    • TABLE 127: Africa Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 128: Africa Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 129: Africa 15-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Dermatology Products, Gastrointestinal Products, Minerals & Vitamins Supplements, Weight Loss/Dietary Products, Ophthalmic Products, Sleep Aids and Other Categories for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 42
Back to Top
전화 문의
F A Q